Double Maxx D.B.M. Capsules

Double Maxx D.B.M. Capsules pose a serious risk to your health and should not be taken.

The Therapeutic Goods Administration (TGA) has tested a product labelled Double Maxx D.B.M. Capsules and found that:

• The capsules contain the undeclared substance Sildenafil.

Consumers are advised that Sildenafil is a prescription-only (S4) medicine in Australia.

The supply of Double Maxx D.B.M. Capsules containing undisclosed Sildenafil is illegal.

Double Maxx D.B.M. Capsules have not been assessed by the TGA for quality, safety or efficacy as required under Australian legislation, and the place of manufacture is not approved by the TGA.

Information for consumers

• Stop taking Double Maxx D.B.M. Capsules and take any remaining capsules to your local pharmacy for safe disposal.
• If you have any concerns arising from your use of this product, consult your health care practitioner.

Action the TGA is taking

The TGA is working with the Australian Border Force (ABF) to help stop future shipments of Double Maxx D.B.M. Capsules from entering Australia.

If these capsules are found at the border by the ABF they will be seized and destroyed.

The TGA is advising consumers to exercise extreme caution when purchasing medicines from unknown overseas internet sites and has produced a short video on the risks associated with buying medicines and medical devices online. Products purchased over the internet:

• may contain undisclosed and potentially harmful ingredients
• may not meet the same standards of quality, safety and efficacy as those approved by the TGA for supply in Australia.

Report counterfeit medicines and medical devices

If you are worried about counterfeit medicines or medical devices, and want to report an issue, you can report the matter to the TGA: